国际标准期刊号: 2573-4555

传统医学和临床自然疗法

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 谷歌学术
  • 夏尔巴·罗密欧
  • 打开 J 门
  • Genamics 期刊搜索
  • 参考搜索
  • 研究期刊索引目录 (DRJI)
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Ayurveda as an Adjuvant Medication for Combating Cancer: A Review

Sumeet Goel, Nisha Ojha and Satyendra Kumar Tiwari

Cancer is one of the most dreaded diseases of the 20th century and spreading further with continuance and increasing incidence in 21st century. At present Chemoprevention and Radiotherapy is main stay of management. But these can produce toxic side effects, which have limited their extensive use. Ayurveda drugs available in different part of the world have been extensively studied for their anti-cancer activity. Ayurveda also have provided with many such drugs which can be proved to be a good anti-cancer substitute to conventional treatment or also provide benefit as an adjuvant therapy. Researches on many such Ayurvedic plants available in India like Azadirachta indica, Carica papaya, Plumbago zeylanica, Ocimum sanctum, Tinospora cordifolia, Catharanthus roseus are reviewed, and found to be effective as anti-cancer in many types of cancers and adjuvant therapy along with chemotherapy and radiotherapy. There is a broad scope to derive the potent anticancer agents from medicinal plants, which need thorough research. Present review reveals the anticancer potential of various Ayurveda drugs so that the findings can be applied in the benefit of cancer patient.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。